Prostate cancer patients can benefit from 5-alpha-reductase inhibitor treatment: a meta-analysis.

Tuo DengXueming LinXiaolu DuanZihao HeZhijian ZhaoGuohua Zeng

Published in: PeerJ (2020)

Our study suggests that 5ARI treatment can benefit patients with local and low Gleason score (≤7) PCa, especially in delaying the disease progression. More studies with larger sample size and comprehensive study design are still needed to verify our outcomes.

Keyphrases

prostate cancer
radical prostatectomy
end stage renal disease
ejection fraction
prognostic factors
skeletal muscle
patient reported outcomes
insulin resistance
glycemic control